Johan Wedell-Wedellsborg, Director, 10% Owner at Y-mAbs Therapeutics, Inc. (YMAB), sold 98,714 shares at $27.02 ($2.7M) on 2019-08-28, disclosed to the SEC on 2019-08-29.
Open-market sale of $2.7M YMAB by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.18 | 19,805 | $538K | 20.1% |
| 2 | $27.18 | 19,805 | $538K | 20.1% |
| 3 | $27.02 | 29,552 | $798K | 29.9% |
| 4 | $27.02 | 29,552 | $798K | 29.9% |
| Total | $27.08 avg | 98,714 | $2.7M | 100% |
| Filing → |
| YMAB | BUY | 2023-12-01 | $619K | — | Filing → |
| YMAB | BUY | 2023-11-29 | $1.0M | — | Filing → |
| YMAB | BUY | 2023-05-17 | $982K | — | Filing → |